{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:55:07Z","timestamp":1782248107095,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Project of China"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173275"],"award-info":[{"award-number":["82173275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072918"],"award-info":[{"award-number":["82072918"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer without effective targeted therapies. Integrative analysis of transcriptomic and proteomic datasets of TNBC in our center revealed that bisphosphate nucleotidase 1 (BPNT1), a member of inositol monophosphatase superfamily with poorly characterized functional and mechanistic roles in human cancer, was abnormally upregulated in TNBC and its high expression was associated with poor patient prognosis. Loss- and gain-of-function assays revealed that BPNT1 acted as a novel oncogenic driver to promote TNBC cell proliferation, migration, invasion in vitro and to accelerate xenograft tumor growth and lung metastasis in mice. Mechanistically, BPNT1 recruited E3 ubiquitin ligase STUB1 (STIP1 homology and U-box containing protein 1) to induce proteasomal degradation of tumor suppressor protein LIMA1 (LIM domain and actin binding 1), thus promoting the epithelial-mesenchymal transition process and TNBC progression. Notably, re-expression of LIMA1 in BPNT1-overexpressing cells partially attenuated BPNT1-driven EMT and malignant phenotypes of TNBC cells. Furthermore, knockdown of BPNT1 enhanced the sensitivity of TNBC cells to the chemotherapeutic agent docetaxel. Collectively, these findings uncover a previously unknown role of the BPNT1-STUB1-LIMA1 axis in progression and docetaxel resistance in TNBC, and highlight BPNT1 as a potential therapeutic target for patients with TNBC.<\/jats:p>","DOI":"10.1038\/s41419-025-08245-0","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:44:13Z","timestamp":1768473853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1"],"prefix":"10.1038","volume":"17","author":[{"given":"Yun-Xiao","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Andriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-0272","authenticated-orcid":false,"given":"Fang-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Min","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-2332","authenticated-orcid":false,"given":"Da-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-4395","authenticated-orcid":false,"given":"Guang-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"8245_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8245_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"8245_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"8245_CR4","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","volume":"12","author":"M Anurag","year":"2022","unstructured":"Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, et al. Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer. Cancer Discov. 2022;12:2586\u2013605.","journal-title":"Cancer Discov"},{"key":"8245_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01504-0","volume":"21","author":"B Wang","year":"2022","unstructured":"Wang B, Zhao Y, Li Y, Xu Y, Chen Y, Jiang Q, et al. A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients. Mol Cancer. 2022;21:22.","journal-title":"Mol Cancer"},{"key":"8245_CR6","doi-asserted-by":"publisher","first-page":"770663","DOI":"10.3389\/fphar.2021.770663","volume":"12","author":"H Tian","year":"2021","unstructured":"Tian H, Ma D, Tan X, Yan W, Wu X, He C, et al. Platinum and Taxane Based adjuvant and neoadjuvant chemotherapy in early triple-negative breast cancer: a narrative review. Front Pharm. 2021;12:770663.","journal-title":"Front Pharm"},{"key":"8245_CR7","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.jbc.2021.101293","volume":"297","author":"BS Eisele","year":"2021","unstructured":"Eisele BS, Luka Z, Wu AJ, Yang F, Hale AT, York JD. Sulfation of glycosaminoglycans depends on the catalytic activity of lithium-inhibited phosphatase BPNT2 in vitro. J Biol Chem. 2021;297:101293.","journal-title":"J Biol Chem"},{"key":"8245_CR8","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1073\/pnas.1205001110","volume":"110","author":"BH Hudson","year":"2013","unstructured":"Hudson BH, Frederick JP, Drake LY, Megosh LC, Irving RP, York JD. Role for cytoplasmic nucleotide hydrolysis in hepatic function and protein synthesis. Proc Natl Acad Sci USA. 2013;110:5040\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8245_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.advenzreg.2011.11.002","volume":"52","author":"BH Hudson","year":"2012","unstructured":"Hudson BH, York JD. Roles for nucleotide phosphatases in sulfate assimilation and skeletal disease. Adv Biol Regul. 2012;52:229\u201338.","journal-title":"Adv Biol Regul"},{"key":"8245_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1016\/j.cub.2016.05.050","volume":"26","author":"JD Meisel","year":"2016","unstructured":"Meisel JD, Kim DH. Inhibition of lithium-sensitive phosphatase bpnt-1 causes selective neuronal dysfunction in C. elegans. Curr Biol. 2016;26:1922\u20138.","journal-title":"Curr Biol"},{"key":"8245_CR11","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1073\/pnas.1715302115","volume":"115","author":"BH Hudson","year":"2018","unstructured":"Hudson BH, Hale AT, Irving RP, Li S, York JD. Modulation of intestinal sulfur assimilation metabolism regulates iron homeostasis. Proc Natl Acad Sci USA. 2018;115:3000\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8245_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jbior.2013.11.002","volume":"54","author":"BH Hudson","year":"2014","unstructured":"Hudson BH, York JD. Tissue-specific regulation of 3\u2019-nucleotide hydrolysis and nucleolar architecture. Adv Biol Regul. 2014;54:208\u201313.","journal-title":"Adv Biol Regul"},{"key":"8245_CR13","doi-asserted-by":"publisher","first-page":"100694","DOI":"10.1016\/j.jbior.2020.100694","volume":"76","author":"AT Hale","year":"2020","unstructured":"Hale AT, Brown RE, Luka Z, Hudson BH, Matta P, Williams CS, et al. Modulation of sulfur assimilation metabolic toxicity overcomes anemia and hemochromatosis in mice. Adv Biol Regul. 2020;76:100694.","journal-title":"Adv Biol Regul"},{"key":"8245_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32847-8","volume":"8","author":"W Li","year":"2018","unstructured":"Li W, Jia H, Li Q, Cui J, Li R, Zou Z, et al. Glycerophosphatidylcholine PC(36:1) absence and 3\u2019-phosphoadenylate (pAp) accumulation are hallmarks of the human glioma metabolome. Sci Rep. 2018;8:14783.","journal-title":"Sci Rep"},{"key":"8245_CR15","doi-asserted-by":"publisher","first-page":"153303382097167","DOI":"10.1177\/1533033820971670","volume":"19","author":"T Luo","year":"2020","unstructured":"Luo T, Du Y, Duan J, Liang C, Chen G, Jiang K, et al. Development and validation of a scoring system based on 9 glycolysis-related genes for prognosis prediction in gastric cancer. Technol Cancer Res Treat. 2020;19:1533033820971670.","journal-title":"Technol Cancer Res Treat"},{"key":"8245_CR16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3892\/or.2015.4150","volume":"34","author":"F An","year":"2015","unstructured":"An F, Zhang Z, Xia M, Xing L. Subpath analysis of each subtype of head and neck cancer based on the regulatory relationship between miRNAs and biological pathways. Oncol Rep. 2015;34:1745\u201354.","journal-title":"Oncol Rep"},{"key":"8245_CR17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35:428\u201340.e5.","journal-title":"Cancer Cell"},{"key":"8245_CR18","doi-asserted-by":"publisher","first-page":"110460","DOI":"10.1016\/j.celrep.2022.110460","volume":"38","author":"TQ Gong","year":"2022","unstructured":"Gong TQ, Jiang YZ, Shao C, Peng WT, Liu MW, Li DQ, et al. Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer. Cell Rep. 2022;38:110460.","journal-title":"Cell Rep"},{"key":"8245_CR19","doi-asserted-by":"publisher","first-page":"e0269208","DOI":"10.1371\/journal.pone.0269208","volume":"17","author":"C Rauskolb","year":"2022","unstructured":"Rauskolb C, Han A, Kirichenko E, Ibar C, Irvine KD. Analysis of the Drosophila Ajuba LIM protein defines functions for distinct LIM domains. PLoS ONE. 2022;17:e0269208.","journal-title":"PLoS ONE"},{"key":"8245_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.cub.2025.01.042","volume":"35","author":"DYZ Phua","year":"2025","unstructured":"Phua DYZ, Sun X, Alushin GM. Force-activated zyxin assemblies coordinate actin nucleation and crosslinking to orchestrate stress fiber repair. Curr Biol. 2025;35:854\u201370.e9.","journal-title":"Curr Biol"},{"key":"8245_CR21","doi-asserted-by":"crossref","unstructured":"Gong W, Zeng J, Ji J, Jia Y, Jia S, Sanders AJ, et al. EPLIN expression in gastric cancer and impact on prognosis and chemoresistance. Biomolecules. 2021;11:547.","DOI":"10.3390\/biom11040547"},{"key":"8245_CR22","doi-asserted-by":"crossref","unstructured":"Li D, Neo SP, Gunaratne J, Sabapathy K. EPLIN-beta is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration. J Cell Sci. 2023;136:jcs260427.","DOI":"10.1242\/jcs.260427"},{"key":"8245_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28139-5","volume":"13","author":"B Duethorn","year":"2022","unstructured":"Duethorn B, Groll F, Rieger B, Drexler HCA, Brinkmann H, Kremer L, et al. Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism. Nat Commun. 2022;13:610.","journal-title":"Nat Commun"},{"key":"8245_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1074\/jbc.M112.438341","volume":"288","author":"S Zhang","year":"2013","unstructured":"Zhang S, Wang X, Iqbal S, Wang Y, Osunkoya AO, Chen Z, et al. Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. J Biol Chem. 2013;288:1469\u201379.","journal-title":"J Biol Chem"},{"key":"8245_CR25","doi-asserted-by":"crossref","unstructured":"Linklater ES, Duncan ED, Han KJ, Kaupinis A, Valius M, Lyons TR, et al. Rab40-Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration. J Cell Biol. 2021;220:e202008060.","DOI":"10.1083\/jcb.202008060"},{"key":"8245_CR26","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1038\/s41388-023-02849-6","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang W, Yang X, Shi K, Zhang Y, Shi X, Wang J, et al. MAD2 activates IGF1R\/PI3K\/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44\/LIMA1 complex. Oncogene. 2023;42:3344\u201357.","journal-title":"Oncogene"},{"key":"8245_CR27","doi-asserted-by":"publisher","first-page":"8190","DOI":"10.1128\/MCB.00661-07","volume":"27","author":"MY Han","year":"2007","unstructured":"Han MY, Kosako H, Watanabe T, Hattori S. Extracellular signal-regulated kinase\/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN. Mol Cell Biol. 2007;27:8190\u2013204.","journal-title":"Mol Cell Biol"},{"key":"8245_CR28","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1073\/pnas.1619356114","volume":"114","author":"NP Chen","year":"2017","unstructured":"Chen NP, Uddin B, Hardt R, Ding W, Panic M, Lucibello I, et al. Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm. Proc Natl Acad Sci USA. 2017;114:5201\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8245_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.CAN-22-2709","volume":"83","author":"L Liao","year":"2023","unstructured":"Liao L, Zhang YL, Deng L, Chen C, Ma XY, Andriani L, et al. Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer Res. 2023;83:471\u201384.","journal-title":"Cancer Res"},{"key":"8245_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/15548627.2022.2103992","volume":"19","author":"TM Zhang","year":"2023","unstructured":"Zhang TM, Liao L, Yang SY, Huang MY, Zhang YL, Deng L, et al. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression. Autophagy. 2023;19:805\u201321.","journal-title":"Autophagy"},{"key":"8245_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","volume":"18","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Liu W, Zhang HM, Xie GY, Miao YR, Xia M, et al. hTFtarget: A Comprehensive database for regulations of human transcription factors and their targets. Genom Proteom Bioinform. 2020;18:120\u20138.","journal-title":"Genom Proteom Bioinform"},{"key":"8245_CR32","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52:D174\u2013D82.","journal-title":"Nucleic Acids Res"},{"key":"8245_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(03)00755-4","volume":"115","author":"J Bloom","year":"2003","unstructured":"Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell. 2003;115:71\u201382.","journal-title":"Cell"},{"key":"8245_CR34","doi-asserted-by":"publisher","first-page":"10850","DOI":"10.1074\/jbc.M109.080796","volume":"285","author":"YT Wu","year":"2010","unstructured":"Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285:10850\u201361.","journal-title":"J Biol Chem"},{"key":"8245_CR35","doi-asserted-by":"publisher","first-page":"42938","DOI":"10.1074\/jbc.M101968200","volume":"276","author":"J Jiang","year":"2001","unstructured":"Jiang J, Ballinger CA, Wu Y, Dai Q, Cyr DM, Hohfeld J, et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J Biol Chem. 2001;276:42938\u201344.","journal-title":"J Biol Chem"},{"key":"8245_CR36","doi-asserted-by":"publisher","first-page":"pgae536","DOI":"10.1093\/pnasnexus\/pgae536","volume":"3","author":"S Shankar","year":"2024","unstructured":"Shankar S, Liu Y, Tulsian NK, Low BC, Lin Q, Sivaraman J. Insights into the regulation of CHIP E3 ligase-mediated ubiquitination of neuronal protein BNIP-H. PNAS Nexus. 2024;3:pgae536.","journal-title":"PNAS Nexus"},{"key":"8245_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.356","volume":"7","author":"CY Huang","year":"2016","unstructured":"Huang CY, Kuo WW, Lo JF, Ho TJ, Pai PY, Chiang SF, et al. Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death. Cell Death Dis. 2016;7:e2455.","journal-title":"Cell Death Dis"},{"key":"8245_CR38","doi-asserted-by":"publisher","first-page":"918183","DOI":"10.1155\/2014\/918183","volume":"2014","author":"I Paul","year":"2014","unstructured":"Paul I, Ghosh MK. The E3 ligase CHIP: insights into its structure and regulation. Biomed Res Int. 2014;2014:918183.","journal-title":"Biomed Res Int"},{"key":"8245_CR39","doi-asserted-by":"crossref","unstructured":"Zhitnyak IY, Rubtsova SN, Litovka NI, Gloushankova NA. Early events in actin cytoskeleton dynamics and E-cadherin-mediated cell-cell adhesion during epithelial-mesenchymal transition. Cells. 2020;9:578.","DOI":"10.3390\/cells9030578"},{"key":"8245_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.21053\/ceo.2023.00025","volume":"17","author":"M Zhang","year":"2024","unstructured":"Zhang M, Peng X, Liang X, Wang W, Yang Y, Xu F, et al. MicroRNA-145-5p regulates the epithelial-mesenchymal transition in nasal polyps by targeting Smad3. Clin Exp Otorhinolaryngol. 2024;17:122\u201336.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"8245_CR41","doi-asserted-by":"crossref","unstructured":"Ciszewski WM, Chmielewska-Kassassir M, Wozniak LA, Sobierajska K. Thymidylate synthase overexpression drives the invasive phenotype in colon cancer cells. Biomedicines. 2022;10:1267.","DOI":"10.3390\/biomedicines10061267"},{"key":"8245_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1083\/jcb.200212057","volume":"160","author":"RS Maul","year":"2003","unstructured":"Maul RS, Song Y, Amann KJ, Gerbin SC, Pollard TD, Chang DD. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J Cell Biol. 2003;160:399\u2013407.","journal-title":"J Cell Biol"},{"key":"8245_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.61","volume":"2","author":"M Saxena","year":"2011","unstructured":"Saxena M, Stephens MA, Pathak H, Rangarajan A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2011;2:e179.","journal-title":"Cell Death Dis"},{"key":"8245_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0203-x","volume":"36","author":"W Wang","year":"2017","unstructured":"Wang W, Wang L, Mizokami A, Shi J, Zou C, Dai J, et al. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling. Chin J Cancer. 2017;36:35.","journal-title":"Chin J Cancer"},{"key":"8245_CR45","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:D955\u201361.","journal-title":"Nucleic Acids Res"},{"key":"8245_CR46","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1111\/mec.15205","volume":"28","author":"DJ Newhouse","year":"2019","unstructured":"Newhouse DJ, Barcelo-Serra M, Tuttle EM, Gonser RA, Balakrishnan CN. Parent and offspring genotypes influence gene expression in early life. Mol Ecol. 2019;28:4166\u201380.","journal-title":"Mol Ecol"},{"key":"8245_CR47","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/ijc.31786","volume":"143","author":"RJ Collins","year":"2018","unstructured":"Collins RJ, Morgan LD, Owen S, Ruge F, Jiang WG, Sanders AJ. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis. Int J Cancer. 2018;143:2537\u201350.","journal-title":"Int J Cancer"},{"key":"8245_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20146-1","volume":"8","author":"N Kasai","year":"2018","unstructured":"Kasai N, Kadeer A, Kajita M, Saitoh S, Ishikawa S, Maruyama T, et al. The paxillin-plectin-EPLIN complex promotes apical elimination of RasV12-transformed cells by modulating HDAC6-regulated tubulin acetylation. Sci Rep. 2018;8:2097.","journal-title":"Sci Rep"},{"key":"8245_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1083\/jcb.201104124","volume":"194","author":"K Taguchi","year":"2011","unstructured":"Taguchi K, Ishiuchi T, Takeichi M. Mechanosensitive EPLIN-dependent remodeling of adherens junctions regulates epithelial reshaping. J Cell Biol. 2011;194:643\u201356.","journal-title":"J Cell Biol"},{"key":"8245_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-71","volume":"7","author":"WG Jiang","year":"2008","unstructured":"Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L, Mansel RE. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer. 2008;7:71.","journal-title":"Mol Cancer"},{"key":"8245_CR51","doi-asserted-by":"publisher","first-page":"117955492211094","DOI":"10.1177\/11795549221109493","volume":"16","author":"W Ma","year":"2022","unstructured":"Ma W, Liao Y, Gao Z, Zhu W, Liu J, She W. Overexpression of LIMA1 indicates poor prognosis and promotes epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Clin Med Insights Oncol. 2022;16:11795549221109493.","journal-title":"Clin Med Insights Oncol"},{"key":"8245_CR52","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jmcb\/mjaa017","volume":"12","author":"D Nguyen","year":"2020","unstructured":"Nguyen D, Yang K, Chiao L, Deng Y, Zhou X, Zhang Z, et al. Inhibition of tumor suppressor p73 by nerve growth factor receptor via chaperone-mediated autophagy. J Mol Cell Biol. 2020;12:700\u201312.","journal-title":"J Mol Cell Biol"},{"key":"8245_CR53","doi-asserted-by":"crossref","unstructured":"Menegatti J, Nakel J, Stepanov YK, Caban KM, Ludwig N, Nord R, et al. Changes of protein expression after CRISPR\/Cas9 knockout of miRNA-142 in cell lines derived from diffuse large B-cell lymphoma. Cancers. 2022;14:5031.","DOI":"10.3390\/cancers14205031"},{"key":"8245_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6908","volume":"6","author":"Z Nie","year":"2015","unstructured":"Nie Z, Du MQ, McAllister-Lucas LM, Lucas PC, Bailey NG, Hogaboam CM, et al. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma. Nat Commun. 2015;6:5908.","journal-title":"Nat Commun"},{"key":"8245_CR55","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cancergen.2012.03.001","volume":"205","author":"D Baumhoer","year":"2012","unstructured":"Baumhoer D, Zillmer S, Unger K, Rosemann M, Atkinson MJ, Irmler M, et al. MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet. 2012;205:212\u20139.","journal-title":"Cancer Genet"},{"key":"8245_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2016.12.034","volume":"390","author":"T Ohashi","year":"2017","unstructured":"Ohashi T, Idogawa M, Sasaki Y, Tokino T. p53 mediates the suppression of cancer cell invasion by inducing LIMA1\/EPLIN. Cancer Lett. 2017;390:58\u201366.","journal-title":"Cancer Lett"},{"key":"8245_CR57","doi-asserted-by":"crossref","unstructured":"Qi Y, Wang H, Zhang Q, Liu Z, Wang T, Wu Z, et al. CAF-Released Exosomal miR-20a-5p Facilitates HCC Progression via the LIMA1-Mediated beta-Catenin Pathway. Cells. 2022;11.","DOI":"10.3390\/cells11233857"},{"key":"8245_CR58","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/j.ymthe.2021.04.036","volume":"29","author":"Z Chu","year":"2021","unstructured":"Chu Z, Huo N, Zhu X, Liu H, Cong R, Ma L, et al. FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect. Mol Ther. 2021;29:2737\u201353.","journal-title":"Mol Ther"},{"key":"8245_CR59","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/0008-5472.CAN-16-2140","volume":"78","author":"H Luan","year":"2018","unstructured":"Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, et al. Loss of the nuclear pool of ubiquitin ligase CHIP\/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program. Cancer Res. 2018;78:2524\u201335.","journal-title":"Cancer Res"},{"key":"8245_CR60","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41418-020-00635-5","volume":"28","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou Y, Zhang P, Li X, Duan C, Zhang C. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma. Cell Death Differ. 2021;28:1026\u201340.","journal-title":"Cell Death Differ"},{"key":"8245_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.652","volume":"12","author":"L Zheng","year":"2022","unstructured":"Zheng L, Feng Z, Tao S, Gao J, Lin Y, Wei X, et al. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-kappaB\/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis. Clin Transl Med. 2022;12:e652.","journal-title":"Clin Transl Med"},{"key":"8245_CR62","doi-asserted-by":"publisher","first-page":"115190","DOI":"10.1016\/j.biopha.2023.115190","volume":"165","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhou H, Tang X. STUB1\/CHIP: new insights in cancer and immunity. Biomed Pharmacother. 2023;165:115190.","journal-title":"Biomed Pharmacother"},{"key":"8245_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00432-013-1571-5","volume":"140","author":"C Sun","year":"2014","unstructured":"Sun C, Li HL, Shi ML, Liu QH, Bai J, Zheng JN. Diverse roles of C-terminal Hsp70-interacting protein (CHIP) in tumorigenesis. J Cancer Res Clin Oncol. 2014;140:189\u201397.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8245_CR64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12272-018-1101-8","volume":"42","author":"J Seo","year":"2019","unstructured":"Seo J, Han SY, Seong D, Han HJ, Song J. Multifaceted C-terminus of HSP70-interacting protein regulates tumorigenesis via protein quality control. Arch Pharm Res. 2019;42:63\u201375.","journal-title":"Arch Pharm Res"},{"key":"8245_CR65","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1038\/s41388-021-01970-8","volume":"40","author":"S Zhang","year":"2021","unstructured":"Zhang S, Guo X, Liu X, Zhong Z, Yang S, Wang H. Adaptor SH3BGRL promotes breast cancer metastasis through PFN1 degradation by translational STUB1 upregulation. Oncogene. 2021;40:5677\u201390.","journal-title":"Oncogene"},{"key":"8245_CR66","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.bbrc.2014.03.061","volume":"446","author":"YN Choi","year":"2014","unstructured":"Choi YN, Lee SK, Seo TW, Lee JS, Yoo SJ. C-Terminus of Hsc70-interacting protein regulates profilin1 and breast cancer cell migration. Biochem Biophys Res Commun. 2014;446:1060\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"8245_CR67","doi-asserted-by":"crossref","unstructured":"Liu RZ, Garg M, Yang XH, Godbout R. Docetaxel-Induced cell death is regulated by a fatty acid-binding protein 12-slug-survivin pathway in prostate cancer cells. Int J Mol Sci. 2024;25:9669.","DOI":"10.3390\/ijms25179669"},{"key":"8245_CR68","doi-asserted-by":"publisher","first-page":"111824","DOI":"10.1016\/j.biopha.2021.111824","volume":"141","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, et al. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother. 2021;141:111824.","journal-title":"Biomed Pharmacother"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08245-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08245-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:03:56Z","timestamp":1768478636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08245-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8245"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08245-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal experimental procedures were approved by the Animal Experiments Committee of FUSCC (Approval Numbers: FUSCC-IACUC-2022445, FUSCC-IACUC-2023290, FUSCC-IACUC-2023437). All tissue samples were obtained under procedures approved by the Medical Ethics Committee of FUSCC (Approval Number: 050432-4-2108), and written informed consent was received from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"40"}}